Are Big Pharma CEOs earning their pay?

While compensation packages at the top may not always reflect value, it’s not necessarily an industrywide problem.

By Kelly Bilodeau • Aug. 8, 2022

Woman of the Week: Alloy Therapeutics’ Heather Schwoebel

The CBO and COO is leaning on her experience navigating the unknown to turn Alloy into an innovation multiplier.

By Taren Grom • Aug. 3, 2022

Explore the Trendline➔

Clinical trial diversity

As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

By PharmaVoice staff

Editas, Real Chemistry and Compass blaze new trails with pivotal C-suite hires

How these latest executive personnel changes are impacting the industry. 

By Karissa Waddick • Aug. 3, 2022

How a speech analysis tool could transform diagnosis and research for Alzheimer’s and beyond

WinterLight’s machine learning platform assesses speech to more accurately identify neurodegenerative diseases.

By Kim Ribbink • Aug. 1, 2022

What’s next for Biogen? Here’s what executives are saying

A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?

By Michael Gibney • July 27, 2022

Woman of the Week: Applied BioMath's Katie Williams

The 2022 president of Women in Bio is equal parts math and gender parity evangelist. 

By Taren Grom • July 27, 2022

With big changes ahead for J&J and Novartis, here's what the companies' execs are talking about

Both J&J and Novartis are making — or considering — big shifts in their fundamental company makeup.

By Michael Gibney • July 21, 2022

Making moves: Agios, BeiGene, Biocom California and more announce new key hires

The latest executive personnel changes from around the industry.

By Karissa Waddick • July 18, 2022

Digital Opinion Leader deep-dive: the sharer

Learn about Digital Opinion Leaders who curate tailored content experiences and provide value to their followers. 

July 18, 2022

Anjarium Biosciences’ CEO on its next-gen gene therapies

Stephen Yoo aims to build on the buzz around the company’s leading-edge gene therapy tech.

By Kim Ribbink • July 15, 2022

Janssen extends LGBTQ mental health outreach beyond Pride Month

The pharma giant’s ‘Depression looks like me’ campaign assembles a ‘one stop shop’ of resources to help combat high rates of severe depression in the LGBTQ community.

By Karissa Waddick • July 14, 2022

Woman of the Week: Kura Oncology's Kirsten Flowers

How the chief commercial and corporate strategy officer is embracing a ‘full-cup’ philosophy to build a better leadership toolbox.

By Taren Grom • July 13, 2022

The power of the underdog: A rare disease nonprofit working to help patients win against the odds

Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

By Alexandra Pecci • July 13, 2022

The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

By Meagan Parrish • July 7, 2022

Woman of the Week: CinCor Pharma's Terry Coelho

From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

By Taren Grom • July 6, 2022

Woman of the Week: Novartis' Marie-France Tschudin

How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

By Taren Grom • June 29, 2022

Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires

The latest personnel changes from around the industry.

By Karissa Waddick • June 29, 2022

The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

By Michael Gibney • June 29, 2022

From vineyards to antivirals, Gilly Regev brings creative thinking to science

The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

By Alexandra Pecci • June 27, 2022

4 tips for landing your next C-suite role in pharma

Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

By Meagan Parrish • June 23, 2022

Woman of the Week: Kronos Bio's Barbara Kosacz

Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.

By Taren Grom • June 21, 2022

The public health sleuth

In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.

By Alexandra Pecci • June 21, 2022

#DIA2022: How the industry's top regulator views the future of healthcare

In the evolution of healthcare, data is the linchpin to making drug development more efficient.

By Michael Gibney • June 21, 2022

A patient-funded ALS drug offers hope where few treatments exist

Eledon Pharmaceuticals’ grassroots-backed drug recently entered clinical trials.

By Kelly Bilodeau • June 15, 2022

Buoyed by COVID-19 shot, J&J's vaccines head sees a new golden age approaching

Janssen’s goal to have ‘a vaccine for the world’ is part of what drew Penny Heaton to the company and its work.

By Alexandra Pecci • June 14, 2022